Cue BioPharma

CUE

18.95011.21% ( +1.910 )

已收盘: 10月21日 16:00:01 (美东)

主要股东最新
股东
Shao-Lee LinPresident, CEO & Director	5.34%	38.78 万	0.92%	+6.03 万	2026/10/12
Bleichroeder LP	5.10%	37.07 万	1.88%	+14.34 万	2026/06/30
Strome Investment Management, L.P.	5.10%	37.04 万	4.09%	+31.78 万	2026/07/14
Driehaus Capital Management LLC	4.02%	29.21 万	--	+29.21 万	2026/06/30
Vanguard Capital Management, LLC	2.56%	18.62 万	0.51%	+8.61 万	2026/06/30
Ikarian Capital, LLC	1.44%	10.44 万	--	+10.44 万	2026/06/30
Tetragon Partners UK LLP	1.29%	9.38 万	--	+9.38 万	2026/06/30
StemPoint Capital LP	0.92%	6.70 万	--	+6.70 万	2026/06/30
Sumita RayChief Legal & Compliance Officer and Corporate Secretary	0.90%	6.55 万	0.14%	+1.09 万	2026/10/12
BlackRock, Inc.	0.80%	5.78 万	0.34%	+4.28 万	2026/06/30
ADAR1 Capital Management, LLC	0.76%	5.52 万	--	+5.52 万	2026/06/30
Lion Point Capital, LP	0.73%	5.29 万	1.53%	-2.05 万	2026/06/30
Mark Strome	0.71%	5.17 万	0.58%	+4.46 万	2026/07/14
Squadron Capital Management LLC	0.69%	5.00 万	--	+5.00 万	2026/06/30
Diadema Partners LP	0.67%	4.84 万	0.53%	+4.40 万	2026/06/30
Geode Capital Management, LLC	0.66%	4.78 万	0.43%	+1.23 万	2026/06/30
Boothbay Fund Management, LLC	0.43%	3.15 万	0.43%	+3.15 万	2026/06/30
UBS Asset Management AG	0.37%	2.67 万	0.28%	+2.38 万	2026/06/30
Citadel Advisors LLC	0.35%	2.56 万	--	+2.56 万	2026/06/30
Texas Capital Bank Wealth Management Services, Inc.	0.31%	2.29 万	0.09%	+9,634.00	2026/06/30

全部股东